Terms: = Liver cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Prognosis
42 results:
1. ZBTB7B is a permissive regulator of hepatocellular carcinoma initiation by repressing c-Jun expression and function.
Zhu Y; Wang Q; Xie X; Ma C; Qiao Y; Zhang Y; Wu Y; Gao Y; Jiang J; Liu X; Chen J; Li C; Ge G
Cell Death Dis; 2024 Jan; 15(1):55. PubMed ID: 38225233
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic impact of MICALL1 and associates with immune infiltration in liver hepatocellular carcinoma patients.
Yang Y; Zhao W; Du J; Wang Y
Cancer Biomark; 2023; 37(3):147-160. PubMed ID: 37248888
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive analysis of cell death genes in hepatocellular carcinoma based on multi-omics data.
Zhang L; Chen X; Guo X; Shen H; Qiu D; Jin W; Hou D
Adv Clin Exp Med; 2023 Feb; 32(2):233-244. PubMed ID: 36753369
[TBL] [Abstract] [Full Text] [Related]
4. Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.
Paulsson JO; Rafati N; DiLorenzo S; Chen Y; Haglund F; Zedenius J; Juhlin CC
J Clin Endocrinol Metab; 2021 Oct; 106(11):3265-3282. PubMed ID: 34171097
[TBL] [Abstract] [Full Text] [Related]
5. Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia.
Ishikawa G; Fujiwara N; Hirschfield H; Varricchio L; Hoshida Y; Barosi G; Rosti V; Padilla M; Mazzarini M; Friedman SL; Hoffman R; Migliaccio AR
Exp Hematol; 2019 Nov; 79():16-25.e3. PubMed ID: 31678370
[TBL] [Abstract] [Full Text] [Related]
6. Rce1 suppresses invasion and metastasis of hepatocellular carcinoma via epithelial-mesenchymal transition induced by the TGF-β1/H-Ras signaling pathway.
Ma C; Yang Y; Xu L; Tu W; Chen F; Wang J
J Cell Physiol; 2020 Mar; 235(3):2506-2520. PubMed ID: 31506952
[TBL] [Abstract] [Full Text] [Related]
7. GEAMP, a novel gastroesophageal junction carcinoma cell line derived from a malignant pleural effusion.
Zhang W; Williams TA; Bhagwath AS; Hiermann JS; Peacock CD; Watkins DN; Ding P; Park JY; Montgomery EA; Forastiere AA; Jie C; Cantarel BL; Pham TH; Wang DH
Lab Invest; 2020 Jan; 100(1):16-26. PubMed ID: 31292541
[TBL] [Abstract] [Full Text] [Related]
8. DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis.
Qu D; Cui F; Lu D; Yang Y; Xu Y
Cancer Sci; 2019 Jan; 110(1):157-165. PubMed ID: 30417471
[TBL] [Abstract] [Full Text] [Related]
9. Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group.
Goey KKH; Sørbye H; Glimelius B; Adams RA; André T; Arnold D; Berlin JD; Bodoky G; de Gramont A; Díaz-Rubio E; Eng C; Falcone A; Grothey A; Heinemann V; Hochster HS; Kaplan RS; Kopetz S; Labianca R; Lieu CH; Meropol NJ; Price TJ; Schilsky RL; Schmoll HJ; Shacham-Shmueli E; Shi Q; Sobrero AF; Souglakos J; Van Cutsem E; Zalcberg J; van Oijen MGH; Punt CJA; Koopman M
Eur J Cancer; 2018 Sep; 100():35-45. PubMed ID: 29936065
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.
Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C
Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440
[TBL] [Abstract] [Full Text] [Related]
11. Tumor regression grades, k-ras mutational profile and c-MET in colorectal liver metastases.
Lorenzon L; Ricca L; Pilozzi E; Lemoine A; Riggio V; Giudice MT; Mallel G; Fochetti F; Balducci G
Pathol Res Pract; 2017 Aug; 213(8):1002-1009. PubMed ID: 28559118
[TBL] [Abstract] [Full Text] [Related]
12. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
[TBL] [Abstract] [Full Text] [Related]
13. [A Case of Rectal cancer with Unresectable liver Metastasis Responding to Rechallenge with FOLFIRI].
Kamiya M; Yoneyama K; Doi Y; Shirai J; Suzuki Y; Hatori S; Yamada T; Sato T; Yamamoto N; Oshima T; Yukawa N; Yoshikawa T; Rino Y; Masuda M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2277-2279. PubMed ID: 28133294
[TBL] [Abstract] [Full Text] [Related]
14. Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain.
Feliu J; Díez de Corcuera I; Manzano JL; Valladares-Ayerbes M; Alcaide J; García García T; Vera R; Sastre J
Clin Transl Oncol; 2017 Apr; 19(4):498-507. PubMed ID: 27718155
[TBL] [Abstract] [Full Text] [Related]
15. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic significance of k-ras mutation rate in metastatic colorectal cancer patients.
Vincenzi B; Cremolini C; Sartore-Bianchi A; Russo A; Mannavola F; Perrone G; Pantano F; Loupakis F; Rossini D; Ongaro E; Bonazzina E; Dell'Aquila E; Imperatori M; Zoccoli A; Bronte G; De Maglio G; Fontanini G; Natoli C; Falcone A; Santini D; Onetti-Muda A; Siena S; Tonini G; Aprile G
Oncotarget; 2015 Oct; 6(31):31604-12. PubMed ID: 26384309
[TBL] [Abstract] [Full Text] [Related]
17. Effects of VEGF/VEGFR/k-ras signaling pathways on miRNA21 levels in hepatocellular carcinoma tissues in rats.
Gao JZ; Wang YL; Li J; Wei LX
Genet Mol Res; 2015 Jan; 14(1):671-9. PubMed ID: 25730004
[TBL] [Abstract] [Full Text] [Related]
18. Reexpression of Let-7g microRNA inhibits the proliferation and migration via k-ras/HMGA2/snail axis in hepatocellular carcinoma.
Chen KJ; Hou Y; Wang K; Li J; Xia Y; Yang XY; Lv G; Xing XL; Shen F
Biomed Res Int; 2014; 2014():742417. PubMed ID: 24724096
[TBL] [Abstract] [Full Text] [Related]
19. [Correlation analysis between abundance of k-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].
Bai YQ; Liu XJ; Wang Y; Ge FJ; Zhao CH; Fu YL; Lin L; Xu JM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):666-71. PubMed ID: 24332053
[TBL] [Abstract] [Full Text] [Related]
20. [Analysis of therapeutic effect and prognosis in patients with metastatic colorectal cancer and different k-ras status].
Ge FJ; Liu JZ; Li SS; Wang Y; Liu LJ; Yao K; Zhao CH; Fu YL; Lin L; Xu JM
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):273-6. PubMed ID: 23985255
[TBL] [Abstract] [Full Text] [Related]
[Next]
